The Institute of Biopharmaceutical and Health Engineering (iBHE) aims to explore the frontiers of health technology and engineering for human wellness to meet the practical needs and long-term development strategy of building a “Healthy China” as well as Shenzhen’s biotechnology industry. The strategy of iBHE is to build international first-class disciplines for providing comprehensive science solutions and awareness-based revolutionary technologies for human health and happiness by integrating pharmaceutical engineering, bioengineering, life sciences, medical sciences, chemical engineering, process and system engineering, materials engineering and other advanced discipline clusters. iBHE will focus on the development of four directions: health engineering, pharmaceutical engineering, vaccine manufacturing, and cell engineering. The institute will build a world-class talent team and create a new interdisciplinary education system in the field of biopharmaceutical and health engineering.
Focusing on two key bottleneck issues for human health, "preventive treatment of diseases" and "prevention and cure from disease sources," our four major research directions include health engineering, pharmaceutical engineering, vaccine engineering, and cell engineering.